Literature DB >> 8025953

Cellular expression of a GPI-linked T cell activation protein.

A Haregewoin1, K Solomon, R C Hom, G Soman, J M Bergelson, A K Bhan, R W Finberg.   

Abstract

A T cell activation protein was identified by generating a monoclonal antibody (anti-D2) against a gamma delta T cell receptor bearing gibbon ape T cell line (MLA144). Immunoprecipitation studies revealed three polypeptides of 180, 150, and 120 kDa. The antigen was also found to be expressed on endothelial cells in vivo and in vitro and on tumor cell lines from a variety of tissues. Studies performed using a variety of antibodies reveal this protein to be identical to an endothelial cell protein previously identified by several antibodies to T cell activation proteins (CDw109). We demonstrate that this protein is anchored in the membrane via a glycosylphosphatidylinositol (GPI) tail in T cells, tumor cells, and endothelial cells. An analysis of tissue sections reveals this protein to be normally highly expressed on vascular endothelial cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8025953     DOI: 10.1006/cimm.1994.1181

Source DB:  PubMed          Journal:  Cell Immunol        ISSN: 0008-8749            Impact factor:   4.868


  11 in total

1.  The association between glycosylphosphatidylinositol-anchored proteins and heterotrimeric G protein alpha subunits in lymphocytes.

Authors:  K R Solomon; C E Rudd; R W Finberg
Journal:  Proc Natl Acad Sci U S A       Date:  1996-06-11       Impact factor: 11.205

2.  CD109, a negative regulator of TGF-β signaling, is a putative risk marker in diffuse large B-cell lymphoma.

Authors:  Maki Yokoyama; Masaaki Ichinoe; Sosei Okina; Yasutaka Sakurai; Norihiro Nakada; Nobuyuki Yanagisawa; Shi-Xu Jiang; Yoshiko Numata; Atsuko Umezawa; Koji Miyazaki; Masaaki Higashihara; Yoshiki Murakumo
Journal:  Int J Hematol       Date:  2016-12-28       Impact factor: 2.490

3.  Determination of the non-ionic detergent insolubility and phosphoprotein associations of glycosylphosphatidylinositol-anchored proteins expressed on T cells.

Authors:  K R Solomon; M A Mallory; R W Finberg
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

4.  Detection of a soluble form of CD109 in serum of CD109 transgenic and tumor xenografted mice.

Authors:  Hiroki Sakakura; Yoshiki Murakumo; Shinji Mii; Sumitaka Hagiwara; Takuya Kato; Masato Asai; Akiyoshi Hoshino; Noriyuki Yamamoto; Sayaka Sobue; Masatoshi Ichihara; Minoru Ueda; Masahide Takahashi
Journal:  PLoS One       Date:  2014-01-06       Impact factor: 3.240

5.  Targeting Myeloid-Derived Suppressor Cells Is a Novel Strategy for Anti-Psoriasis Therapy.

Authors:  Chao Chen; Lirong Tan; Wu Zhu; Li Lei; Yehong Kuang; Panpan Liu; Jie Li; Xiang Chen; Cong Peng
Journal:  Mediators Inflamm       Date:  2020-06-28       Impact factor: 4.711

6.  Phenotypic Plasticity of Invasive Edge Glioma Stem-like Cells in Response to Ionizing Radiation.

Authors:  Mutsuko Minata; Alessandra Audia; Junfeng Shi; Songjian Lu; Joshua Bernstock; Marat S Pavlyukov; Arvid Das; Sung-Hak Kim; Yong Jae Shin; Yeri Lee; Harim Koo; Kirti Snigdha; Indrayani Waghmare; Xing Guo; Ahmed Mohyeldin; Daniel Gallego-Perez; Jia Wang; Dongquan Chen; Peng Cheng; Farah Mukheef; Minerva Contreras; Joel F Reyes; Brian Vaillant; Erik P Sulman; Shi-Yuan Cheng; James M Markert; Bakhos A Tannous; Xinghua Lu; Madhuri Kango-Singh; L James Lee; Do-Hyun Nam; Ichiro Nakano; Krishna P Bhat
Journal:  Cell Rep       Date:  2019-02-12       Impact factor: 9.423

7.  Serum CD109 levels reflect the node metastasis status in head and neck squamous cell carcinoma.

Authors:  Sumitaka Hagiwara; Eiichi Sasaki; Yasuhisa Hasegawa; Hidenori Suzuki; Daisuke Nishikawa; Shintaro Beppu; Hoshino Terada; Michi Sawabe; Masahide Takahashi; Nobuhiro Hanai
Journal:  Cancer Med       Date:  2021-02-09       Impact factor: 4.452

8.  Metabolic and Immunological Subtypes of Esophageal Cancer Reveal Potential Therapeutic Opportunities.

Authors:  Ryan J King; Fang Qiu; Fang Yu; Pankaj K Singh
Journal:  Front Cell Dev Biol       Date:  2021-07-08

9.  Human platelet antigen genotyping and expression of CD109 (human platelet antigen 15) mRNA in various human cell types.

Authors:  Sang Mee Hwang; Mi Jung Kim; Ho Eun Chang; Yun Ji Hong; Taek Soo Kim; Eun Young Song; Kyoung Un Park; Junghan Song; Kyou-Sup Han
Journal:  Biomed Res Int       Date:  2013-02-12       Impact factor: 3.411

10.  Suppression of skin tumorigenesis in CD109-deficient mice.

Authors:  Masaki Sunagawa; Shinji Mii; Atsushi Enomoto; Takuya Kato; Yoshiki Murakumo; Yukihiro Shiraki; Naoya Asai; Masato Asai; Masato Nagino; Masahide Takahashi
Journal:  Oncotarget       Date:  2016-12-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.